Skip to main content
. 2019 Mar 26;16(3):784–796. doi: 10.1007/s13311-019-00726-3

Fig. 2.

Fig. 2

Effects of Suvorexant on beta activity (20–35 Hz) in 5-month-old R6/1 mice. Plots of average power spectra showing that a single oral administration of Suvorexant (30 mg/kg) decreased the power of the beta activity during REM sleep (a) and SWS (b) but not wakefulness (c). Theta (6–10 Hz) power strongly expressed during REM sleep was not modified (a). Data are presented as mean ± SEM